ES2173165T3 - Metodo para obtener reactivos para diagnosticos, dosificados y terapias basado en la manifestaciones clinicas de una emfermedad. - Google Patents
Metodo para obtener reactivos para diagnosticos, dosificados y terapias basado en la manifestaciones clinicas de una emfermedad.Info
- Publication number
- ES2173165T3 ES2173165T3 ES95902582T ES95902582T ES2173165T3 ES 2173165 T3 ES2173165 T3 ES 2173165T3 ES 95902582 T ES95902582 T ES 95902582T ES 95902582 T ES95902582 T ES 95902582T ES 2173165 T3 ES2173165 T3 ES 2173165T3
- Authority
- ES
- Spain
- Prior art keywords
- antibodies
- peptides
- molecules
- disease
- bound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 201000010099 disease Diseases 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- 239000003153 chemical reaction reagent Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 238000012216 screening Methods 0.000 abstract 3
- 241001515965 unidentified phage Species 0.000 abstract 2
- 238000002372 labelling Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
- C07K16/109—Hepatitis C virus; Hepatitis G virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/82—Hepatitis associated antigens and antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Virology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Computational Biology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
SE RECUPERAN ANTICUERPOS Y SE AISLAN DEL SERUM DE UN NUMERO "N" DE PACIENTES, CADA UNO DE LOS CUALES HA TENIDO LA MISMA ENFERMEDAD DADA, DE FORMA QUE CADA UNO DE ESTOS PACIENTES TENGA, DENTRO DE UN AMPLIO NUMERO DE ANTICUERPOS DISTINTOS, ALGUNOS ANTICUERPOS ASOCIADOS UNICAMENTE CON LA MISMA ENFERMEDAD DE INTERES. LOS ANTICUERPOS DE UN PRIMER PACIENTE ESTAN FIJADOS A UNA SUPERFICIE DE SOPORTE. PARA LLEVAR A CABO ARCHIVOS DE SEGUIMIENTO INICIALES DE MOLECULAS, TALES COMO PEPTIDOS MOSTRADOS EN LA SUPERFICIE DE LA BACTERIOFAGIA, SE PONEN EN CONTACTO CON LOS ANTICUERPOS FIJADOS DEL PRIMER PACIENTE BAJO CONDICIONES EN LAS QUE SE PRODUZCA LA UNION. LAS MOLECULAS NO FIJADAS (PEPTIDAS) SE ELIMINAN Y LAS MOLECULAS FIJADAS (PEPTIDAS) SOBRE LA BACTERIOFAGIA SON IDENTIFICADAS. SE REALIZA ENTONCES UN SEGUIMIENTO SECUNDARIO EXTRAYENDO Y ETIQUETANDO LOS ANTICUERPOS DE UN SEGUNDO PACIENTE Y UTILIZANDO LOS ANTICUERPOS ETIQUETADOS PARA PROBAR LAS MOLECULAS (AISLADAS) EN EL SEGUIMIENTO INICIAL.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/155,943 US5492807A (en) | 1993-11-19 | 1993-11-19 | Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2173165T3 true ES2173165T3 (es) | 2002-10-16 |
Family
ID=22557410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95902582T Expired - Lifetime ES2173165T3 (es) | 1993-11-19 | 1994-11-17 | Metodo para obtener reactivos para diagnosticos, dosificados y terapias basado en la manifestaciones clinicas de una emfermedad. |
Country Status (11)
Country | Link |
---|---|
US (2) | US5492807A (es) |
EP (2) | EP1150121A3 (es) |
JP (1) | JP3135126B2 (es) |
AT (1) | ATE213836T1 (es) |
AU (1) | AU674471B2 (es) |
CA (1) | CA2175374A1 (es) |
DE (1) | DE69429999T2 (es) |
DK (1) | DK0729517T3 (es) |
ES (1) | ES2173165T3 (es) |
PT (1) | PT729517E (es) |
WO (1) | WO1995014110A1 (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1270939B (it) * | 1993-05-11 | 1997-05-26 | Angeletti P Ist Richerche Bio | Procedimento per la preparazione di immunogeni e reagenti diagnostici,e immunogeni e reagenti diagnostici cosi' ottenibili. |
US5492807A (en) * | 1993-11-19 | 1996-02-20 | Santi; Daniel V. | Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease |
ITPN960013A1 (it) * | 1996-02-26 | 1997-08-26 | Marcello Piazza | Farmaco atto a proteggere l'individuo dal contagio di epatite virale, ecc. |
GB9810756D0 (en) | 1998-05-19 | 1998-07-15 | Angeletti P Ist Richerche Bio | Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof |
WO2000023140A1 (en) | 1998-10-16 | 2000-04-27 | Mission Medical, Inc. | Blood processing system |
JP2004515751A (ja) | 2000-09-08 | 2004-05-27 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | インビトロターゲティングのための方法および組成物 |
US7452964B2 (en) | 2001-09-07 | 2008-11-18 | Board Of Regents, The University Of Texas System | Compositions and methods of use of targeting peptides against placenta and adipose tissues |
US20050074747A1 (en) * | 2000-09-08 | 2005-04-07 | Wadih Arap | Biopanning and rapid analysis of selective interactive ligands (brasil) |
US20040170955A1 (en) | 2000-09-08 | 2004-09-02 | Wadih Arap | Human and mouse targeting peptides identified by phage display |
US7420030B2 (en) * | 2000-09-08 | 2008-09-02 | The Board Of Regents Of The University Of Texas System | Aminopeptidase A (APA) targeting peptides for the treatment of cancer |
US20040176290A1 (en) * | 2001-07-18 | 2004-09-09 | Renata Pasqualini | Anti-angiogenic state in mice and humans with retinal photorecptor cell degeneration |
US20040048243A1 (en) * | 2001-09-07 | 2004-03-11 | Wadih Arap | Methods and compositions for in vitro targeting |
US8507445B2 (en) * | 2001-09-07 | 2013-08-13 | Board Of Regents, The University Of Texas System | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
US7671010B2 (en) * | 2002-08-30 | 2010-03-02 | The Board Of Regents Of The University Of Texas System | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
US7863004B2 (en) * | 2001-12-04 | 2011-01-04 | Wayne State University | Neoepitope detection of disease using protein arrays |
US8877901B2 (en) | 2002-12-13 | 2014-11-04 | Immunomedics, Inc. | Camptothecin-binding moiety conjugates |
US7591994B2 (en) | 2002-12-13 | 2009-09-22 | Immunomedics, Inc. | Camptothecin-binding moiety conjugates |
AU2003903317A0 (en) * | 2003-06-27 | 2003-07-10 | Proteome Systems Intellectual Property Pty Ltd | Method of isolating a protein |
GB0422431D0 (en) * | 2004-10-08 | 2004-11-10 | Affitech As | Method |
WO2007046818A2 (en) * | 2004-11-16 | 2007-04-26 | Board Of Regents, The University Of Texas System | Compositions and methods related to synchronous selection of homing peptides for multiple tissues by in vivo phage display |
WO2006060171A2 (en) * | 2004-11-16 | 2006-06-08 | Board Of Regents, The University Of Texas System | Methods and compositions related to phage-nanoparticle assemblies |
EP3470087A1 (en) | 2009-02-13 | 2019-04-17 | Immunomedics, Inc. | Lyophilised compositions of immunoconjugates with an intracellularly-cleavable linkage |
AU2010343304B2 (en) | 2010-01-19 | 2013-06-20 | Immunomedics, Inc. | Novel class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type I receptor (IGF-1R) |
KR20230078823A (ko) | 2012-12-13 | 2023-06-02 | 이뮤노메딕스, 인코오포레이티드 | 개선된 효능 및 감소된 독성을 위한 항체 및 sn-38의 면역컨쥬게이트의 투약 |
US10768181B2 (en) | 2013-12-17 | 2020-09-08 | The Brigham And Women's Hospital, Inc. | Detection of an antibody against a pathogen |
WO2016057398A1 (en) | 2014-10-07 | 2016-04-14 | Immunomedics, Inc. | Neoadjuvant use of antibody-drug conjugates |
JP6980980B2 (ja) | 2015-06-25 | 2021-12-15 | イミューノメディクス、インコーポレイテッドImmunomedics, Inc. | 抗hla‐drまたは抗trop‐2抗体と微小管阻害剤、parp阻害剤、ブルトンキナーゼ阻害剤またはホスホイノシチド3‐キナーゼ阻害剤との併用は癌の治療効果を有意に改善する |
EP3316885B1 (en) | 2015-07-01 | 2021-06-23 | Immunomedics, Inc. | Antibody-sn-38 immunoconjugates with a cl2a linker |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3586772T2 (de) * | 1984-07-24 | 1993-03-04 | Coselco Mimotopes Pty Ltd | Verfahren zur bestimmung von mimotopen. |
US4751181A (en) * | 1984-12-31 | 1988-06-14 | Duke University | Methods and compositions useful in the diagnosis and treatment of autoimmune diseases |
WO1986006487A1 (en) * | 1985-04-22 | 1986-11-06 | Commonwealth Serum Laboratories Commission | Method for determining mimotopes |
US5010175A (en) * | 1988-05-02 | 1991-04-23 | The Regents Of The University Of California | General method for producing and selecting peptides with specific properties |
US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5182366A (en) * | 1990-05-15 | 1993-01-26 | Huebner Verena D | Controlled synthesis of peptide mixtures using mixed resins |
US5270170A (en) * | 1991-10-16 | 1993-12-14 | Affymax Technologies N.V. | Peptide library and screening method |
IT1270939B (it) | 1993-05-11 | 1997-05-26 | Angeletti P Ist Richerche Bio | Procedimento per la preparazione di immunogeni e reagenti diagnostici,e immunogeni e reagenti diagnostici cosi' ottenibili. |
US5492807A (en) * | 1993-11-19 | 1996-02-20 | Santi; Daniel V. | Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease |
-
1993
- 1993-11-19 US US08/155,943 patent/US5492807A/en not_active Expired - Fee Related
-
1994
- 1994-11-17 AT AT95902582T patent/ATE213836T1/de not_active IP Right Cessation
- 1994-11-17 CA CA002175374A patent/CA2175374A1/en not_active Abandoned
- 1994-11-17 PT PT95902582T patent/PT729517E/pt unknown
- 1994-11-17 DK DK95902582T patent/DK0729517T3/da active
- 1994-11-17 DE DE69429999T patent/DE69429999T2/de not_active Expired - Fee Related
- 1994-11-17 AU AU11804/95A patent/AU674471B2/en not_active Ceased
- 1994-11-17 EP EP01118834A patent/EP1150121A3/en not_active Withdrawn
- 1994-11-17 EP EP95902582A patent/EP0729517B1/en not_active Expired - Lifetime
- 1994-11-17 JP JP07514594A patent/JP3135126B2/ja not_active Expired - Fee Related
- 1994-11-17 ES ES95902582T patent/ES2173165T3/es not_active Expired - Lifetime
- 1994-11-17 WO PCT/US1994/013241 patent/WO1995014110A1/en active IP Right Grant
-
1995
- 1995-11-17 US US08/558,235 patent/US5670312A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0729517A1 (en) | 1996-09-04 |
EP0729517A4 (en) | 1997-10-15 |
EP1150121A2 (en) | 2001-10-31 |
AU674471B2 (en) | 1996-12-19 |
PT729517E (pt) | 2002-08-30 |
DE69429999D1 (de) | 2002-04-04 |
JPH09500731A (ja) | 1997-01-21 |
EP1150121A3 (en) | 2004-01-07 |
EP0729517B1 (en) | 2002-02-27 |
ATE213836T1 (de) | 2002-03-15 |
DE69429999T2 (de) | 2002-08-29 |
JP3135126B2 (ja) | 2001-02-13 |
US5492807A (en) | 1996-02-20 |
DK0729517T3 (da) | 2002-04-22 |
WO1995014110A1 (en) | 1995-05-26 |
CA2175374A1 (en) | 1995-05-26 |
US5670312A (en) | 1997-09-23 |
AU1180495A (en) | 1995-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2173165T3 (es) | Metodo para obtener reactivos para diagnosticos, dosificados y terapias basado en la manifestaciones clinicas de una emfermedad. | |
NO913186L (no) | Fremgangsmaate for anvendelse og syntese av peptider. | |
DK165197B (da) | Fremgangsmaade til bestemmelse af mimotoper | |
DK0980429T3 (da) | Human Toll-lignende receptorproteiner, beslægtede reagenser og fremgangsmåder | |
ES2047334T3 (es) | Metodo de analisis optico. | |
WO1986006487A1 (en) | Method for determining mimotopes | |
DE69030947D1 (de) | Monoklonaler Antikörper spezifisch für ein humanes atherom-assoziiertes Antigen | |
AU629886B2 (en) | Diagnostic test using chimeric antibodies | |
DE69531345D1 (de) | Rekombinant pgp3, verfahren zu dessen herstellung, und dessen verwendung in der diagnose und therapie | |
SE8701905L (sv) | Foerfarande och kit foer diagnos av iga-nefropati | |
RU2005108044A (ru) | Эпитопы т-клеток в стафилококковом энтеротоксине в | |
ATE265533T1 (de) | Saeugetierchemokine | |
DE69534178D1 (en) | S?ugetier thymokingene | |
AU2003260516A8 (en) | Immunochromatography system and method for the simultaneous identification of aga and t-tg antibodies and use thereof for the diagnosis of celiac disease | |
AR002004A1 (es) | Proteina slam, anticuerpo o un fragmento del mismo que se fija a dicha proteina, metodo de purificacion, acido nucleico que codifica dicha proteina,vector de expresion, equipo que la contiene, metodo de deteccion, metodo de modulacion y metodo para preparar una composicion farmaceutica. | |
Santi | Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease | |
DK479687A (da) | Antistoffer mod modificeret beta2-mikroglobulin samt diagnostika og praeparater indeholdende disse | |
ES1009161Y (es) | Soporte para tubos de ensayo para analisis clinicos. | |
BG48880A1 (en) | Hybrodomic cell line mus musculus b 6/3, secretizing monoclonal antibodies against rickettsia conorii | |
DE19930933A1 (de) | Verfahren zur Bestimmung von anti-LKM 1-Antikörpern |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 729517 Country of ref document: ES |